Items per page

Search results

Items: 1 to 20 of 129

Search results: x Variables, w Analyses, x Documents, and z Datasets in x Studies
Clinical VariableDatasetVariable DescriptionVariable ID
The data table contains mapping of study subject IDs to sample IDs for subjects with chronic renal insufficiency. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. Also included is the sample use.
Sample usephv00173296.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Medication Indicator: Antiplateletphv00173198.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Creatinine Serum (mg/dL)phv00173192.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Total score of Modified Mini Mental State Examphv00173275.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Medication Indicator: Alpha blockersphv00173195.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Urine Protein (grams/24 hours)phv00173266.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Number of Hypertension Meds, truncated at 4phv00173272.v1.p1
This data table contains subject IDs and consent group information for subjects with chronic renal insufficiency.
Consent group as determined by DACphv00173169.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Roche Adjusted Serum Creatinine (mg/dL)phv00173269.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Peripheral Vascular Diseasephv00173246.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
>100 Cigarettesphv00173243.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
CO2 (mmol/L)phv00173240.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Biguanide Medication Indicatorphv00173214.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Medication Indicator: Calciferols (Vit D2 and D3 from Supplements)phv00173237.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Medication Indicator: vasodilatorsphv00173211.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Diabetic at Baselinephv00173288.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Calcium (mg/dL)phv00173182.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Magnesium (mg/dL)phv00173185.v1.p1
The subject phenotype data table includes self-reported medical history (n=9 variables; asthma, arthritis, COPD, MI/prior revascularization, PVD, CHF, stroke, any CVD, and atrial fibrillation/heart arrythmia), family history (n=2 variables; CAD and renal disease), anthropometric measurements (n=5 variables; height, weight, BMI, BSA, and waist), blood pressure and pulse measures (systolic/diastolic, MAP, pulse, ankle brachial indices), CO2 measurement, lipid data (n=5 variables), diabetes screening (n=2 variables), eGFR, serum lab measurements (n=16 variables), CBC measurements (n=2 variables), urine lab measurements (n=3 variables), Becks and MMSE scores, smoking status (n=2 variables), alcohol use, medications (n=3 variables), and medication indicators (n=47 variables).
Medication Indicator: Non-selective SRIsphv00173208.v1.p1
The sample attributes data table includes sample analyte type (DNA or RNA), body site where samples were collected, is tumor status, and histological type.
File ID for IDAT filesphv00173291.v1.p1
Items per page

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center